2012-02-12T16:00:00Z
European Markets; Asian Markets; Global Market Data ... and Chief Executive Officer of InterMune, Inc. since May ... Officer of Salmedix, Inc., a biotechnology company. From May ...

2012-02-13T15:22:00Z
InterMune - The Black Knight Of Biotech? ... much an open question whether it would stay on the market in Europe. ... it may be pulled/restricted in Europe and the ...

2012-02-15T23:07:00Z
InterMune Inc. had a record gain in Nasdaq Stock Market composite trading after a European regulatory committee recommended approval of its ... Europe may ... Open ...

2012-02-14T09:25:00Z
The biotechnology company ... Stock Market composite trading. InterMune has more than tripled since December, when a European ... in the European Union may ...

2012-02-16T13:44:00Z
3:23 p.m. May 10, 2011 - Kate Gibson ... Regeneron, InterMune lead biotech stocks south. 2:11 p.m ... every time the media and the markets panic over the Europe ...

2012-02-15T18:55:00Z
... InterMune Inc. shares plummeted after the biotech said ... Market Pulse Archives. May 4, 2010, 5:35 p.m. EDT InterMune drops after ... and the markets panic over the Europe ...

2012-02-12T13:46:00Z
Open Polls ... major European markets in 2012. In connection with the EU approval, InterMune ... Biotechnology News (GEN) has retained its position ...

2012-02-16T03:41:00Z
... covered InterMune's overview of pirfenidone and its market ... group does open the door ... in an open-label phase 2 study, so this may be a minor issue. 3. InterMune's ...

2012-02-11T11:18:00Z
InterMune Widens Loss, Sales Dip - Analyst Blog 1 hour ago – ... European Market May Open its Doors to This Biotech January 13, 2011 – NASDAQ

2012-02-13T12:06:00Z
... to the Esbriet launch, prior to the open of the U.S. markets ... time for any software downloads that may ... About InterMune InterMune is a biotechnology company focused on ...

2012-02-14T18:40:00Z
InterMune is a biotechnology company focused on the research ... of Esbriet (pirfenidone) in Europe. InterMune's Marketing ... Open-label therapy will be administered to ...

2012-02-14T21:27:00Z
... to the creation of InterMune's European ... InterMune is a biotechnology company focused on the ... having an FVC endpoint may not be satisfactory to the FDA for InterMune ...

2012-02-11T21:53:00Z
... may opt to sell all or a significant chunk of its holdings in InterMune Inc., the ... came as InterMune lines up the European launch of its ... DeLorean doors ...

2012-01-01T18:51:00Z
... 50 per share on EMEA approval as European market 2 ... This material may not be published in its entirety or ... Monday Market Outlook: An Open Week in Equities

2012-02-14T04:03:00Z
Last night, a high-flying biotech, InterMune, was brought ... Although the European decision now becomes much ... there were no other treatments on the market”, they [Intermune ...